The Health Cluster funds activities which aims at improving and protecting the health and well-being of citizens of all ages by generating new knowledge, developing innovative solutions and integrating where relevant a gender perspective to prevent, diagnose, monitor, treat and cure diseases.
Introduction to Health
The Health Cluster also funds projects developing health technologies, mitigating health risks, protecting populations and promoting good health and well-being in general and at work.
In addition, the Health Cluster aims to make public health systems more cost-effective, equitable and sustainable, prevent and tackle poverty-related diseases and support and enable patients’ participation and self-management.
Areas funded include:
- health throughout the life course
- environmental and social health determinants
- non-communicable and rare diseases
- infectious diseases including poverty-related and neglected diseases
- tools, technologies and digital solutions for health and care including personalised medicine
- health care systems
Citizens of all ages stay healthy and independent in a rapidly changing society thanks to healthier lifestyles and behaviours, healthier diets, healthier environments, improved evidence-based health policies, and more effective solutions for health promotion and disease prevention.
Health care providers are able to better tackle and manage diseases (infectious diseases, including poverty-related and neglected diseases, non-communicable and rare diseases) and reduce the disease burden on patients effectively thanks to better understanding and treatment of diseases, more effective and innovative health technologies, better ability and preparedness to manage epidemic outbreaks and improved patient safety.
Health care systems provide equal access to innovative, sustainable and high-quality health care thanks to the development and uptake of safe, cost-effective and people-centred solutions, with a focus on population health, health systems resilience, as well as improved evidence-based health policies.
Health technologies, new tools and digital solutions are applied effectively thanks to their inclusive, secure and ethical development, delivery, integration and deployment in health policies and health care systems.
EU health industry is innovative, sustainable and globally competitive thanks to improved up-take of breakthrough technologies and innovations, which makes the EU with its Member States more resilient and less dependent from imports with regard to the access to and supply of critical health technologies.
The Innovative Health Initiative is a public-private partnership (PPP) between the EU and the European life science industries. IHI follows on from the Innovative Medicines Initiative (IMI), but is broader and covers the entire continuum of care, from prevention, diagnostics, to treatment and disease management. IHI’s goal is translate health research and innovation into tangible benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research. IHI has a total budget of €2.4 billion.
It is funded jointly by the EU (with €1.2 billion coming from Horizon Europe) and industry organisations representing Europe’s life science industries (represented by COCIR, EFPIA / Vaccines Europe, EuropaBio and MedTech Europe). The IHI website contains further information on: who is eligible for IHI funding; funding opportunities; events; the IHI Strategic Research and Innovation Agenda (SRIA) and a newsletter sign-up form. As well as the calls already announced, there will also be other future calls up until 2027.
Global Health EDCTP3 aims to deliver new solutions reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities for preparedness and response against re-emerging infectious diseases both in sub-Saharan African and globally. It has total funding of 1.6 billion (consisting of €800m from Horizon Europe, at least €400m from the EDCTP Association and €400m from others including industry and philanthropic organisations). The 2022 Work Programme is available, whilst the Strategic Research and Innovation Agenda (SRIA) includes more information on their objectives and priorities. Sign up to the EDCTP newsletter to stay up to date. As well as the calls already announced, there will also be other future calls up until 2027.
JPIAMR is a global collaborative organisation and platform, engaging 29 nations to curb antimicrobial resistance (AMR) with a One Health approach. Their website includes participating members/countries, calls, newsletter signup, activities/events and their Strategic Research and Innovation Agenda (SRIA). The 2023 Call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance” has been pre-announced on the JPIAMR and UKRI websites. UK funders participating in this call are Innovate UK, MRC, BBSRC and EPSRC. A live webinar for applicants will be organised on the 24th of January 2023. This webinar will present the call and the partner search tool.
EU Missions related to the Health Cluster are:
Cancer Mission – The goal of the Cancer Mission is work alongside the Europe’s Beating Cancer Plan to improve the lives of more than 3 million people by 2030 through prevention, cure and solutions to live longer and better. It has four objectives:
1. Understanding cancer
2. Prevention and early detection
3. Diagnosis and treatment
4. Quality of life for patients and their families
The Cancer Mission will be implemented through various EU programmes, including the EU’s Horizon Europe research and innovation funding programme. Horizon Europe will provide €378.2 million of funding for the Cancer Mission in the 2021-2023 calls. As well as the calls already announced, there are also likely to be other future calls up until 2027.
Introduction to EU Missions
EU Missions are a new way to bring concrete solutions to some of our greatest challenges. EU Missions are a coordinated effort by the Commission to pool the necessary resources in terms of funding programmes, policies and regulations, as well as other activities.
Introduction to EU Partnerships
EU Partnerships are initiatives where the EU, national authorities and/or the private sector jointly commit to support the development and implementation of a programme of research and innovation activities.
Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Publishes Pre-Announcement: Research call on AMR diagnostics and surveillance
The JPIAMR will launch a Call in 2023: ‘Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance’ worth up to approximately 18,8 million Euro.
What's next for R&D if the UK is unable to associate to Horizon Europe?
The UK government has confirmed successful Horizon Europe applicants will receive funding from UKRI regardless of the outcome of the UK’s efforts to associate with Horizon Europe.
Related Events and Recordings
Overview of Horizon Europe Clusters - Webinar Series
10.00 - 12.00 GMT | Online
Register for this event
6th EUREKA SMART Cluster in Advanced Manufacturing
10.00 - 11.00 | Online
Horizon Europe Consortia Building Series
09.00 - 17.00 | Online
Sign up for the UKRI Horizon Europe Newsletter to find out about EU News, Events and Funding Opportunities.
Sign up to the Global Alliance Newsletter for Horizon Europe news, events and funding and to learn more about Innovate UK KTN’s European and International Projects and Programmes.
If you are considering applying for Horizon Europe, you may find the recording and slides from our ‘Horizon Europe Consortia Building’ event useful.